RecruitingNot ApplicableNCT05608694

MRI Screening in Men at High Risk of Developing Prostate Cancer


Sponsor

University of Chicago

Enrollment

250 participants

Start Date

Mar 2, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is for men at high risk of developing prostate cancer (due to family history, genetics, or other factors). It looks at whether regular MRI scans can help detect prostate cancer earlier than traditional methods like PSA testing and biopsy. **You may be eligible if...** - You are a male aged 18 or older - You have no known history of prostate cancer - You have not had any previous prostate removal or ablation procedures (such as TURP) **You may NOT be eligible if...** - You cannot tolerate an MRI scan due to metal implants or claustrophobia - You do not have a rectum - You have a hip replacement that would interfere with MRI imaging Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERProstate MRI

Group placement is determined by GRS score, Family history, and germline testing


Locations(2)

University of Chicago

Chicago, Illinois, United States

NorthShore University Health System - Glenbrook Hospital

Glenview, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05608694


Related Trials